Compounds > 1-(2-chloroethyl)-3-(1-oxyl-2,2,6,6-tetramethylpiperidinyl)-1-nitrosourea
Page last updated: 2024-12-08
1-(2-chloroethyl)-3-(1-oxyl-2,2,6,6-tetramethylpiperidinyl)-1-nitrosourea
Description
The compound you're describing is **1-(2-chloroethyl)-3-(1-oxyl-2,2,6,6-tetramethylpiperidinyl)-1-nitrosourea**. It's a bit of a mouthful, and you'll often see it referred to by its shorter name, **CCNU**.
**CCNU is an alkylating agent, a type of chemotherapy drug.** Here's a breakdown of its components and their significance:
* **1-Nitrosourea:** This is the core functional group responsible for the drug's cytotoxic (cell-killing) activity. It releases a highly reactive nitrogen-containing species that can damage DNA within cancer cells.
* **1-(2-chloroethyl):** This portion of the molecule is also involved in the alkylating process. It can react with DNA, creating cross-links that interfere with its function.
* **3-(1-oxyl-2,2,6,6-tetramethylpiperidinyl):** This part of the molecule, sometimes referred to as the TEMPO group, is a stable free radical. This allows for CCNU to be studied with techniques like electron paramagnetic resonance (EPR) spectroscopy.
**CCNU's Importance in Research:**
CCNU has been historically important in cancer research, particularly in the treatment of **brain tumors**. However, it is **no longer widely used clinically** due to its severe side effects.
Here's why it remains relevant in research:
* **Understanding Cancer Biology:** CCNU has been instrumental in understanding how alkylating agents work at the molecular level, providing insight into the mechanisms of DNA damage and repair.
* **Development of New Drugs:** The structure of CCNU has served as a basis for the development of newer and safer alkylating agents, such as lomustine, which have fewer side effects.
* **Probing Cell Processes:** The TEMPO group makes CCNU a useful tool for studying various biological processes, including:
* The delivery and uptake of drugs into cells.
* The mechanisms of drug resistance.
* The dynamics of free radical reactions in living systems.
**Overall, while CCNU is not a standard treatment for cancer today, it remains an important research tool for studying cancer biology and for developing new and more effective anti-cancer agents.**
1-(2-chloroethyl)-3-(1-oxyl-2,2,6,6-tetramethylpiperidinyl)-1-nitrosourea: has more antineoplastic activity & less toxicity than CCNU; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 134164 |
MeSH ID | M0131160 |
Synonyms (9)
Synonym |
unii-w77mz42gar |
slnu |
slcnu |
1-(2-chloroethyl)-3-(1-oxyl-2,2,6,6-tetramethylpiperidinyl)-1-nitrosourea |
nu 2 |
brn 5985884 |
83144-41-6 |
DTXSID401003160 |
[4-({[(2-chloroethyl)(nitroso)amino](hydroxy)methylidene}amino)-2,2,6,6-tetramethylpiperidin-1-yl]oxidanyl |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.24
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.24 (24.57) | Research Supply Index | 2.08 (2.92) | Research Growth Index | 4.32 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |